Abstract
Autoinflammation is a category of human immune dysregulation best exemplified by inborn errors in genes important for innate immunity. Though overproduction of cytokines is a mechanistic feature of most autoinflammatory diseases, only a few have been associated with the phenotype of Cytokine Storm. Rarely, the most severe presentations of some canonical autoinflammatory diseases have featured cytokine storm. Innate immune activation is also part of the pathogenesis of canonical cytokine storm disorders, like hemophagocytic lymphohistiocytosis. More recently, biomarker, mechanistic, and early treatment studies in patients with Still’s disease, or with NLRC4 or XIAP mutations, have placed the inflammasome-activated cytokine IL-18 at the center of the intersection of autoinflammation and cytokine storm.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Goldstein, B., Giroir, B., & Randolph, A. (2005). International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatric Critical Care Medicine, 6(1), 2–8. https://doi.org/10.1097/01.PCC.0000149131.72248.E6
Pras, E., Aksentijevich, I., Gruberg, L., Balow Jr., J. E., Prosen, L., Dean, M., et al. (1992). Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. The New England Journal of Medicine, 326(23), 1509–1513. https://doi.org/10.1056/NEJM199206043262301
McDermott, M. F., Aksentijevich, I., Galon, J., McDermott, E. M., Ogunkolade, B. W., Centola, M., et al. (1999). Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell, 97(1), 133–144.
Hoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A., & Kolodner, R. D. (2001). Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nature Genetics, 29(3), 301–305. https://doi.org/10.1038/ng756
Feldmann, J., Prieur, A. M., Quartier, P., Berquin, P., Certain, S., Cortis, E., et al. (2002). Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. American Journal of Human Genetics, 71(1), 198–203.
Aksentijevich, I., Nowak, M., Mallah, M., Chae, J. J., Watford, W. T., Hofmann, S. R., et al. (2002). De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis and Rheumatism, 46(12), 3340–3348. https://doi.org/10.1002/art.10688
de Jesus, A. A., Canna, S. W., Liu, Y., & Goldbach-Mansky, R. (2015). Molecular mechanisms in genetically defined autoinflammatory diseases: Disorders of amplified danger signaling. Annual Review of Immunology, 33, 823–874. https://doi.org/10.1146/annurev-immunol-032414-112227
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004). NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity, 20(3), 319–325.
Broz, P., & Dixit, V. M. (2016). Inflammasomes: Mechanism of assembly, regulation and signalling. Nature Reviews. Immunology, 16(7), 407–420. https://doi.org/10.1038/nri.2016.58
Park, Y. H., Wood, G., Kastner, D. L., & Chae, J. J. (2016). Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nature Immunology, 17(8), 914–921. https://doi.org/10.1038/ni.3457
Canna, S. W., de Jesus, A. A., Gouni, S., Brooks, S. R., Marrero, B., Liu, Y., et al. (2014). An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nature Genetics, 46(10), 1140–1146. https://doi.org/10.1038/ng.3089
Romberg, N., Al Moussawi, K., Nelson-Williams, C., Stiegler, A. L., Loring, E., Choi, M., et al. (2014). Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nature Genetics, 46(10), 1135–1139. https://doi.org/10.1038/ng.3066
Goldbach-Mansky, R., Dailey, N. J., Canna, S. W., Gelabert, A., Jones, J., Rubin, B. I., et al. (2006). Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. The New England Journal of Medicine, 355(6), 581–592. https://doi.org/10.1056/NEJMoa055137
Hawkins, P. N., Lachmann, H. J., Aganna, E., & McDermott, M. F. (2004). Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis and Rheumatism, 50(2), 607–612. https://doi.org/10.1002/art.20033
Tsoukas, P., & Canna, S. W. (2017). No shortcuts: New findings reinforce why nuance is the rule in genetic autoinflammatory syndromes. Current Opinion in Rheumatology, 29(5), 506–515. https://doi.org/10.1097/BOR.0000000000000422
Manthiram, K., Zhou, Q., Aksentijevich, I., & Kastner, D. L. (2017). The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nature Immunology, 18(8), 832–842. https://doi.org/10.1038/ni.3777
Lykens, J. E., Terrell, C. E., Zoller, E. E., Risma, K., & Jordan, M. B. (2011). Perforin is a critical physiologic regulator of T-cell activation. Blood. https://doi.org/10.1182/blood-2010-12-324533
Rood, J. E., Rao, S., Paessler, M., Kreiger, P. A., Chu, N., Stelekati, E., et al. (2016). ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice. Blood, 127(4), 426–435. https://doi.org/10.1182/blood-2015-07-659813
Jordan, M. B., Locatelli, F., Allen, C., de Benedetti, F., Grom, A., Ballabio, M., et al. (2015). Abstract: A novel targeted approach to the treatment of hemophagocytic lymphohistiocytosis (HLH) with an anti-interferon gamma (IFNγ) monoclonal antibody (mAb), NI-0501: First results from a pilot phase 2 study in children with primary HLH. Blood, 126(23), LBA-3.
Rice, G., Patrick, T., Parmar, R., Taylor, C. F., Aeby, A., Aicardi, J., et al. (2007). Clinical and molecular phenotype of Aicardi-Goutieres syndrome. American Journal of Human Genetics, 81(4), 713–725. https://doi.org/10.1086/521373
Tungler, V., Konig, N., Gunther, C., Engel, K., Fiehn, C., Smitka, M., et al. (2016). Response to: ‘JAK inhibition in STING-associated interferonopathy’ by Crow et al. Annals of the Rheumatic Diseases, 75(12), e76. https://doi.org/10.1136/annrheumdis-2016-210565
Aksentijevich, I., Masters, S. L., Ferguson, P. J., Dancey, P., Frenkel, J., van Royen-Kerkhoff, A., et al. (2009). An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. The New England Journal of Medicine, 360(23), 2426–2437. https://doi.org/10.1056/NEJMoa0807865
Mendonca, L. O., Malle, L., Donovan, F. X., Chandrasekharappa, S. C., Montealegre Sanchez, G. A., Garg, M., et al. (2017). Deficiency of interleukin-1 receptor antagonist (DIRA): Report of the first Indian patient and a novel deletion affecting IL1RN. Journal of Clinical Immunology, 37(5), 445–451. https://doi.org/10.1007/s10875-017-0399-1
Koc, B., Oktenli, C., Bulucu, F., Karadurmus, N., Sanisoglu, S. Y., & Gul, D. (2007). The rate of pyrin mutations in critically ill patients with systemic inflammatory response syndrome and sepsis: A pilot study. The Journal of Rheumatology, 34(10), 2070–2075.
Rodrigue-Gervais, I. G., & Saleh, M. (2010). Genetics of inflammasome-associated disorders: A lesson in the guiding principals of inflammasome function. European Journal of Immunology, 40(3), 643–648. https://doi.org/10.1002/eji.200940225
Schulert, G. S., Zhang, M., Fall, N., Husami, A., Kissell, D., Hanosh, A., et al. (2016). Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza. The Journal of Infectious Diseases, 213(7), 1180–1188. https://doi.org/10.1093/infdis/jiv550
Krebs, P., Crozat, K., Popkin, D., Oldstone, M. B., & Beutler, B. (2011). Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice. Blood, 117(24), 6582–6588. https://doi.org/10.1182/blood-2011-01-329607
Zoller, E. E., Lykens, J. E., Terrell, C. E., Aliberti, J., Filipovich, A. H., Henson, P. M., et al. (2011). Hemophagocytosis causes a consumptive anemia of inflammation. The Journal of Experimental Medicine, 208(6), 1203–1214. https://doi.org/10.1084/jem.20102538
Wunderlich, M., Stockman, C., Devarajan, M., Ravishankar, N., Sexton, C., Kumar, A. R., et al. (2016). A xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatment. JCI Insight, 1(15), e88181. https://doi.org/10.1172/jci.insight.88181
Sepulveda, F. E., Maschalidi, S., Vosshenrich, C. A., Garrigue, A., Kurowska, M., Menasche, G., et al. (2014). A novel immunoregulatory role for NK cell cytotoxicity in protection from HLH-like immunopathology in mice. Blood, 125(9), 1427–1434. https://doi.org/10.1182/blood-2014-09-602946
Ombrello, M. J., Remmers, E. F., Tachmazidou, I., Grom, A., Foell, D., Haas, J. P., et al. (2015). HLA-DRB1∗11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. Proceedings of the National Academy of Sciences of the United States of America, 112(52), 15970–15975. https://doi.org/10.1073/pnas.1520779112
De Benedetti, F., Brunner, H. I., Ruperto, N., Kenwright, A., Wright, S., Calvo, I., et al. (2012). Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. The New England Journal of Medicine, 367(25), 2385–2395. https://doi.org/10.1056/NEJMoa1112802
Ruperto, N., Brunner, H. I., Quartier, P., Constantin, T., Wulffraat, N., Horneff, G., et al. (2012). Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. The New England Journal of Medicine, 367(25), 2396–2406. https://doi.org/10.1056/NEJMoa1205099
Ombrello, M. J., Arthur, V. L., Remmers, E. F., Hinks, A., Tachmazidou, I., Grom, A. A., et al. (2016). Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: Clinical and therapeutic implications. Annals of the Rheumatic Diseases, 76(5), 906–913. https://doi.org/10.1136/annrheumdis-2016-210324
Shimizu, M., Nakagishi, Y., Inoue, N., Mizuta, M., Ko, G., Saikawa, Y., et al. (2015). Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Clinical Immunology, 160(2), 277–281. https://doi.org/10.1016/j.clim.2015.06.005
Girard, C., Rech, J., Brown, M., Allali, D., Roux-Lombard, P., Spertini, F., et al. (2016). Elevated serum levels of free interleukin-18 in adult-onset Still’s disease. Rheumatology (Oxford), 55(12), 2237–2247. https://doi.org/10.1093/rheumatology/kew300
Gabay, C., Fautrel, B., Rech, J., Spertini, F., Feist, E., Kotter, I., et al. (2018). Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2017-212608
Weiss, E. S., Girard-Guyonvarc’h, C., Holzinger, D., de Jesus, A. A., Tariq, Z., Picarsic, J., et al. (2018). Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. Blood, 131(13), 1442–1455. https://doi.org/10.1182/blood-2017-12-820852
Liang, J., Alfano, D. N., Squires, J. E., Riley, M. M., Parks, W. T., Kofler, J., et al. (2017). Novel NLRC4 mutation causes a syndrome of perinatal autoinflammation with hemophagocytic lymphohistiocytosis, hepatosplenomegaly, fetal thrombotic vasculopathy, and congenital anemia and ascites. Pediatric and Developmental Pathology, 20(6), 498–505.
Moghaddas, F., Zeng, P., Zhang, Y., Schutzle, H., Brenner, S., Hofmann, S. R., et al. (2018). Autoinflammatory mutation in NLRC4 reveals an LRR-LRR oligomerization interface. The Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2018.04.033
Canna, S. W., Girard, C., Malle, L., de Jesus, A., Romberg, N., Kelsen, J., et al. (2016). Life-threatening NLRC4-associated hyperinflammation successfully treated with Interleukin-18 inhibition. The Journal of Allergy and Clinical Immunology, 139(5), 1698–1701. https://doi.org/10.1016/j.jaci.2016.10.022
Bracaglia, C., Prencipe, G., Gatto, A., Pardeo, M., Lapeyre, G., Raganelli, L., et al. (2015). Anti interferon-gamma (IFN gamma) monoclonal antibody treatment in a child with NLRC4-related disease and severe hemophagocytic lymphohistiocytosis (HLH). Pediatric Blood & Cancer, 62, S123–S123.
Bracaglia, C., de Graaf, K., Pires Marafon, D., Guilhot, F., Ferlin, W., Prencipe, G., et al. (2017). Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Annals of the Rheumatic Diseases, 76(1), 166–172. https://doi.org/10.1136/annrheumdis-2015-209020
Girard-Guyonvarc’h, C., Palomo, J., Martin, P., Rodriguez, E., Troccaz, S., Palmer, G., et al. (2018). Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice. Blood, 131(13), 1430–1441. https://doi.org/10.1182/blood-2017-06-789552
Rigaud, S., Fondaneche, M. C., Lambert, N., Pasquier, B., Mateo, V., Soulas, P., et al. (2006). XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature, 444(7115), 110–114. https://doi.org/10.1038/nature05257
Marsh, R. A., Madden, L., Kitchen, B. J., Mody, R., McClimon, B., Jordan, M. B., et al. (2010). XIAP deficiency: A unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood, 116(7), 1079–1082. https://doi.org/10.1182/blood-2010-01-256099
Lawlor, K. E., Feltham, R., Yabal, M., Conos, S. A., Chen, K. W., Ziehe, S., et al. (2017). XIAP loss triggers RIPK3- and caspase-8-driven IL-1beta activation and cell death as a consequence of TLR-MyD88-induced cIAP1-TRAF2 degradation. Cell Reports, 20(3), 668–682. https://doi.org/10.1016/j.celrep.2017.06.073
Kenneth, N. S., & Duckett, C. S. (2012). IAP proteins: Regulators of cell migration and development. Current Opinion in Cell Biology, 24(6), 871–875. https://doi.org/10.1016/j.ceb.2012.11.004
Yabal, M., Muller, N., Adler, H., Knies, N., Gross, C. J., Damgaard, R. B., et al. (2014). XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. Cell Reports, 7(6), 1796–1808. https://doi.org/10.1016/j.celrep.2014.05.008
Wada, T., Kanegane, H., Ohta, K., Katoh, F., Imamura, T., Nakazawa, Y., et al. (2014). Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. Cytokine, 65(1), 74–78. https://doi.org/10.1016/j.cyto.2013.09.007
Gernez, Y., de Jesus, A. A., Alsaleem, H., Macaubas, C., Roy, A., Lovell, D., et al. (2019). Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 (CDC42) successfully treated with IL-1beta inhibition. The Journal of Allergy and Clinical Immunology, epub Jul 2. https://doi.org/10.1016/j.jaci.2019.06.017
Speckmann, C., Lehmberg, K., Albert, M. H., Damgaard, R. B., Fritsch, M., Gyrd-Hansen, M., et al. (2013). X-linked inhibitor of apoptosis (XIAP) deficiency: The spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clinical Immunology, 149(1), 133–141. https://doi.org/10.1016/j.clim.2013.07.004
Kitamura, A., Sasaki, Y., Abe, T., Kano, H., & Yasutomo, K. (2014). An inherited mutation in NLRC4 causes autoinflammation in human and mice. The Journal of Experimental Medicine, 211(12), 2385–2396. https://doi.org/10.1084/jem.20141091
Volker-Touw, C. M., de Koning, H. D., Giltay, J., de Kovel, C., van Kempen, T. S., Oberndorff, K., et al. (2016). Erythematous nodes, urticarial rash and arthralgias in a large pedigree with NLRC4-related autoinflammatory disease, expansion of the phenotype. The British Journal of Dermatology, 176(1), 244–248. https://doi.org/10.1111/bjd.14757
Kawasaki, Y., Oda, H., Ito, J., Niwa, A., Tanaka, T., Hijikata, A., et al. (2017). Identification of a high-frequency somatic NLRC4 mutation as a cause of autoinflammation by pluripotent cell-based phenotype dissection. Arthritis & Rheumatology, 69(2), 447–459. https://doi.org/10.1002/art.39960
de Jager, W., Vastert, S. J., Beekman, J. M., Wulffraat, N. M., Kuis, W., Coffer, P. J., et al. (2009). Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis and Rheumatism, 60(9), 2782–2793. https://doi.org/10.1002/art.24750
Put, K., Vandenhaute, J., Avau, A., van Nieuwenhuijze, A., Brisse, E., Dierckx, T., et al. (2017). Inflammatory gene expression profile and defective interferon-gamma and granzyme K in natural killer cells from systemic juvenile idiopathic arthritis patients. Arthritis & Rheumatology, 69(1), 213–224. https://doi.org/10.1002/art.39933
Munoz, M., Eidenschenk, C., Ota, N., Wong, K., Lohmann, U., Kuhl, A. A., et al. (2015). Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection. Immunity, 42(2), 321–331. https://doi.org/10.1016/j.immuni.2015.01.011
Nowarski, R., Jackson, R., Gagliani, N., de Zoete, M. R., Palm, N. W., Bailis, W., et al. (2015). Epithelial IL-18 equilibrium controls barrier function in colitis. Cell, 163(6), 1444–1456. https://doi.org/10.1016/j.cell.2015.10.072
Rauch, I., Deets, K. A., Ji, D. X., von Moltke, J., Tenthorey, J. L., Lee, A. Y., et al. (2017). NAIP-NLRC4 inflammasomes coordinate intestinal epithelial cell expulsion with eicosanoid and IL-18 release via activation of caspase-1 and -8. Immunity, 46(4), 649–659. https://doi.org/10.1016/j.immuni.2017.03.016
Chudnovskiy, A., Mortha, A., Kana, V., Kennard, A., Ramirez, J. D., Rahman, A., et al. (2016). Host-protozoan interactions protect from mucosal infections through activation of the inflammasome. Cell, 167(2), 444–456.e414. https://doi.org/10.1016/j.cell.2016.08.076
Shakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., et al. (2016). Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: Reanalysis of a prior phase III trial. Critical Care Medicine, 44(2), 275–281. https://doi.org/10.1097/CCM.0000000000001402
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Canna, S.W. (2019). The Intersections of Autoinflammation and Cytokine Storm. In: Cron, R., Behrens, E. (eds) Cytokine Storm Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-030-22094-5_24
Download citation
DOI: https://doi.org/10.1007/978-3-030-22094-5_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-22093-8
Online ISBN: 978-3-030-22094-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)